Journal articleClin Cancer Res2020
CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.
- Journal
- Clin Cancer Res
- Published
- 1 September 2020
- Citations
- 16
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- CXCR3 in Pancreatic Cancer Progression and Metastasis F30CA225117↗
- Mucin Splice Variants in Pancreatic Cancer Diagnosis and Pathogenesis F31CA243469↗
- Project 1: The Role and Mechanism(s) of MUC16 and MUC16-Cter in Potentiating PC Metastasis P01CA217798↗
- Rac1 GTPase in tumorigenesis and progression of pancreatic cancer R01CA206444↗
- Targeting CXCR2 axis in Pancreatic Cancer R01CA228524↗
- Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma U01CA200466↗
- Pancreatic Cancer Detection Consortium U01CA210240↗